These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18681750)

  • 1. Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program.
    van Winkel R; van Os J; Celic I; Van Eyck D; Wampers M; Scheen A; Peuskens J; De Hert M
    J Clin Psychiatry; 2008 Aug; 69(8):1319-27. PubMed ID: 18681750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index.
    Laursen TM; Agerbo E; Pedersen CB
    J Clin Psychiatry; 2009 Oct; 70(10):1432-8. PubMed ID: 19538905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors for metabolic syndrome in schizophrenia, schizoaffective, and bipolar disorder.
    Mohd Ahmed H; Abdel Aziz K; Al Ammari A; Galadari M; Alsaadi A; Alhassani A; Al Marzooqi F; AlAhbabi M; Alsheryani H; Bahayan M; Ahmed R; Alameri S; Stip E; Aly El-Gabry D
    Int J Psychiatry Clin Pract; 2024 Mar; 28(1):35-44. PubMed ID: 38329470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
    Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
    J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family history of psychiatric illness as a risk factor for schizoaffective disorder: a Danish register-based cohort study.
    Laursen TM; Labouriau R; Licht RW; Bertelsen A; Munk-Olsen T; Mortensen PB
    Arch Gen Psychiatry; 2005 Aug; 62(8):841-8. PubMed ID: 16061761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality of severe mental disorder diagnoses in a national health registry as compared to research diagnoses based on structured interview.
    Nesvåg R; Jönsson EG; Bakken IJ; Knudsen GP; Bjella TD; Reichborn-Kjennerud T; Melle I; Andreassen OA
    BMC Psychiatry; 2017 Mar; 17(1):93. PubMed ID: 28292279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PATIENTS WITH SCHIZOPHRENIA, BIPOLAR DISORDER AND SCHIZOAFFECTIVE DISORDER].
    Muñoz-Calero Franco P; Sánchez Sánchez B; Rodríguez Criado N; Pinilla Santos B; Bravo Herrero S; Cruz Fourcade JF; Martín Aragón R
    Nutr Hosp; 2015 Dec; 32(6):2715-7. PubMed ID: 26667725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: evaluation of incidence and screening methods.
    van Winkel R; De Hert M; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
    J Clin Psychiatry; 2006 Oct; 67(10):1493-500. PubMed ID: 17107239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study.
    Birkenaes AB; Opjordsmoen S; Brunborg C; Engh JA; Jonsdottir H; Ringen PA; Simonsen C; Vaskinn A; Birkeland KI; Friis S; Sundet K; Andreassen OA
    J Clin Psychiatry; 2007 Jun; 68(6):917-23. PubMed ID: 17592917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil.
    Teixeira PJ; Rocha FL
    Braz J Psychiatry; 2007 Dec; 29(4):330-6. PubMed ID: 18200397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 24-month prospective outcome study of first-episode schizophrenia and schizoaffective disorder within an early psychosis intervention program.
    Sim K; Chan YH; Chong SA; Siris SG
    J Clin Psychiatry; 2007 Sep; 68(9):1368-76. PubMed ID: 17915975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder.
    Pagel T; Baldessarini RJ; Franklin J; Baethge C
    Bipolar Disord; 2013 May; 15(3):229-39. PubMed ID: 23528024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic significance of Schneiderian first-rank symptoms: a 20-year longitudinal study of schizophrenia and bipolar disorder.
    Rosen C; Grossman LS; Harrow M; Bonner-Jackson A; Faull R
    Compr Psychiatry; 2011; 52(2):126-31. PubMed ID: 21295217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease--there is no schizoaffective disorder.
    Lake CR; Hurwitz N
    Curr Opin Psychiatry; 2007 Jul; 20(4):365-79. PubMed ID: 17551352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety disorder comorbidity in bipolar disorder, schizophrenia and schizoaffective disorder.
    Young S; Pfaff D; Lewandowski KE; Ravichandran C; Cohen BM; Öngür D
    Psychopathology; 2013; 46(3):176-85. PubMed ID: 22906962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
    Peralta V; Cuesta MJ
    J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.
    Correll CU; Smith CW; Auther AM; McLaughlin D; Shah M; Foley C; Olsen R; Lencz T; Kane JM; Cornblatt BA
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):475-90. PubMed ID: 18928412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.